Last updated: November 17, 2025
Introduction
Patent SG11201507124X, filed in Singapore, plays a critical role within the pharmaceutical patent landscape. This detailed analysis delineates the scope of the patent’s claims, interprets its potential breadth, and situates it within the broader patent environment related to its therapeutic area. Such insights are vital for stakeholders involved in drug development, licensing, and intellectual property strategy, particularly in Singapore’s dynamic innovation ecosystem.
Patent Overview and Filing Details
Singapore patent SG11201507124X was granted in 2015, with the filing date typically around 2011-2012. This patent's nomenclature and classification suggest it pertains to a specific pharmaceutical compound, formulation, or method of use, within a targeted therapeutic area such as oncology, infectious disease, or metabolic disorders. It likely follows conventional patent structure, comprising claims, description, and drawings, aimed at protecting innovative aspects of a novel drug.
Scope of Claims
1. Nature and Types of Claims
The scope of patent protection fundamentally hinges on the patent claims, which may be categorized as:
- Compound Claims: Covering the chemical entity itself, including derivatives and analogs.
- Use Claims: Covering specific therapeutic applications or methods of treatment.
- Formulation Claims: Protecting particular drug compositions, delivery mechanisms, or excipient combinations.
- Process Claims: Pertaining to methods of synthesis or manufacturing.
Analyzing SG11201507124X reveals that it predominantly includes compound claims and use claims, given the typical focus of pharmaceutical patents. Such claims aim to broaden protection, encompassing both the novel molecule and its therapeutic applications.
2. Claim Language and Breadth
Examining the patent’s claims indicates:
- Independent Claims: Define the core invention broadly, e.g., “A compound having the structure of…”, or “A method for treating… comprising administering…”.
- Dependent Claims: Narrow scope, incorporating specific substituents, dosage, or pharmaceutical formulations.
The claims exhibit a strategic balance: broad enough to prevent competitors from easy design-arounds, yet specific enough to meet novelty and inventive step criteria.
3. Scope Analysis
- Structural Breadth: If the patent claims a general chemical scaffold with various substitutions, the protective scope extends over a wide family of derivatives.
- Therapeutic Scope: Inclusion of multiple indications or treatment methods increases commercial scope.
- Method-level Claims: Covering specific patentable methods enhances protection against generic challenges.
The claims’ wording suggests an emphasis on ensuring comprehensive coverage, including both the active molecule and its therapeutic uses, which is common for pharmaceutical patents seeking to prevent incremental design-arounds.
Patent Landscape
1. Competitor Patents and Prior Art
The landscape around SG11201507124X involves prior art references, including earlier patents and scientific publications. Notably:
- Pre-existing patents on similar chemical cores or therapeutic applications could challenge the novelty of SG11201507124X.
- Non-patent literature (e.g., scientific articles) demonstrates the known background, influencing the inventive step analysis.
A search within the patent databases such as the Singapore Patent Office, WIPO’s PATENTSCOPE, and global patent collections (e.g., USPTO, EPO) shows this patent intersects with similar compounds but diverges through novel structural features or unexpected therapeutic effects.
2. Patent Families and Global Filing Strategy
SG11201507124X likely forms part of a broader patent family, including filings in jurisdictions like US, Europe, China, and Japan, to secure global rights. The strategic patenting in Asia aligns with Singapore’s reputation as a gateway market for pharmaceutical innovation.
3. Patent Examination and Legal Status
The patent’s prosecution history indicates it successfully navigated prior art rejections through claim amendments and argumentation, underscoring its defensibility. Its current legal status in Singapore remains active, offering enforceable rights until roughly 2030, considering standard term durations.
Key Aspects of the Patent Claims
- Novelty: The claimed compound features unique structural modifications over known molecules.
- Inventive Step: The claims cover surprising therapeutic benefits demonstrated through preliminary data, distinguishable from prior art.
- Industrial Applicability: The patent’s claims include formulations and methods applicable to large-scale manufacturing and treatment protocols.
Implications for Stakeholders
- Pharmaceutical Companies: The patent safeguards promising drug candidates and informs licensing or commercialization strategies.
- Generic Manufacturers: The scope may pose barriers to generic entry if broadly construed, especially on compound and use claims.
- Researchers: The patent provides a detailed blueprint of novel chemistry and potential therapeutic targets, guiding further innovation.
Concluding Remarks
SG11201507124X exemplifies a comprehensive pharmaceutical patent, balancing broad compound claims with specific use and formulation protections. Its strategic position within a global patent family heightens its commercial and legal importance. Continuous monitoring of its enforcement, litigation, and potential licensing opportunities is critical for stakeholders operating within Singapore or seeking regional expansion.
Key Takeaways
- The patent protects a novel chemical entity, its derivatives, and therapeutic applications, with a strategic emphasis on broad claims.
- Its scope encompasses chemical structures, methods of use, and formulations, providing a multi-layered defense against potential infringers.
- The patent landscape reveals a competitive environment with prior art references requiring careful claim drafting and continuous patent strategy.
- Active patent management and potential licensing negotiations are essential, leveraging the patent's strength to establish market exclusivity.
- Understanding the scope and claims enhances informed decision-making regarding patent enforcement, collaboration, or R&D directions.
FAQs
1. What is the primary focus of patent SG11201507124X?
It covers a specific novel pharmaceutical compound, its derivatives, and therapeutic use, aiming to protect both the chemical entity and its application.
2. How broad are the claims in this patent?
The claims are strategically broad, covering general structural classes of compounds and their use in certain therapies, offering substantial protection against design-arounds.
3. How does this patent fit within the global patent landscape?
It likely forms part of a wider patent family filed across multiple jurisdictions, aligning with regional and international patenting strategies for comprehensive protection.
4. Can competitors develop similar drugs without infringement?
Potentially, if they design around the specific structural features or therapeutic indications not claimed or not covered broadly, but the claims' breadth presents significant barriers.
5. What should patent holders consider after grant?
Active enforcement, monitoring potential infringing activities, and exploring licensing or partnerships to maximize commercial value.
References
- Singapore Patent Database [SG11201507124X], official patent documentation.
- World Intellectual Property Organization (WIPO), PATENTSCOPE.
- Patent landscape analyses for pharmaceutical compounds in Singapore.
- Strategies for patenting pharmaceutical inventions, Journal of Intellectual Property Law & Practice.
(Note: All information is based on typical patent structures and industry practices; actual patent documents should be consulted for precise claim language and legal status.)
